Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
It is unclear whether children with HIV and severe acute malnutrition can be started on
highly active antiretroviral therapy (HAART) safely while they are still malnourished and the
manner in which this therapy should start. This study will examine the safety, efficacy, and
metabolism of children started on HAART while still severely malnourished.